Article
[Genetic tests in oncology: from identification of high risk groups to therapy].
Igiene e sanita pubblica - 1 Jan 2000
Sgambato Alessandro, Ripani Maurizio, Romano Spica Vincenzo
Abstract excerpt
The development of genetic epidemiology in oncology has made possible more frequent analysis of high risk groups, allowing the development of promising susceptibility indicators. The main public health implications include screening and new perspectives for pharmacogenetics and nutrigenomics. The study of genetic variants allows the evaluation of individual risk of developing a disease and has important...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
